193 related articles for article (PubMed ID: 25545125)
21. Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis.
Kim MP; Park SI; Kopetz S; Gallick GE
Cell Tissue Res; 2009 Jan; 335(1):249-59. PubMed ID: 18815812
[TBL] [Abstract][Full Text] [Related]
22. Advances in targeting SRC in the treatment of breast cancer and other solid malignancies.
Mayer EL; Krop IE
Clin Cancer Res; 2010 Jul; 16(14):3526-32. PubMed ID: 20634194
[TBL] [Abstract][Full Text] [Related]
23. Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells.
Nam S; Kim D; Cheng JQ; Zhang S; Lee JH; Buettner R; Mirosevich J; Lee FY; Jove R
Cancer Res; 2005 Oct; 65(20):9185-9. PubMed ID: 16230377
[TBL] [Abstract][Full Text] [Related]
24. Src family kinase potentiates the activity of nicotinic acetylcholine receptor in rat autonomic ganglion innervating urinary bladder.
Kim NH; Park KS; Cha SK; Yoon JH; Yeh BI; Han KH; Kong ID
Neurosci Lett; 2011 May; 494(3):190-5. PubMed ID: 21396981
[TBL] [Abstract][Full Text] [Related]
25. SRC family kinase activity is required for murine embryonic stem cell growth and differentiation.
Meyn MA; Schreiner SJ; Dumitrescu TP; Nau GJ; Smithgall TE
Mol Pharmacol; 2005 Nov; 68(5):1320-30. PubMed ID: 15985613
[TBL] [Abstract][Full Text] [Related]
26. Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors.
Roskoski R
Pharmacol Res; 2015 Apr; 94():9-25. PubMed ID: 25662515
[TBL] [Abstract][Full Text] [Related]
27. SRC inhibitors as potential therapeutic agents for human cancers.
Trevino JG; Summy JM; Gallick GE
Mini Rev Med Chem; 2006 Jun; 6(6):681-7. PubMed ID: 16787379
[TBL] [Abstract][Full Text] [Related]
28. Recent progress of SRC family kinase inhibitors as anticancer agents.
Cao X; You QD; Li ZY; Wang XJ; Lu XY; Liu XR; Xu D; Liu B
Mini Rev Med Chem; 2008 Sep; 8(10):1053-63. PubMed ID: 18782057
[TBL] [Abstract][Full Text] [Related]
29. Reduced expression of SRC family kinases decreases PI3K activity in NBS1-/- lymphoblasts.
Sagan D; Eckardt-Schupp F; Eichholtz-Wirth H
Biochem Biophys Res Commun; 2008 Dec; 377(1):181-6. PubMed ID: 18835245
[TBL] [Abstract][Full Text] [Related]
30. Emerging role for SRC family kinases in junction dynamics during spermatogenesis.
Xiao X; Yang Y; Mao B; Cheng CY; Ni Y
Reproduction; 2019 Mar; 157(3):R85-R94. PubMed ID: 30608903
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors.
Montero JC; Seoane S; Ocaña A; Pandiella A
Clin Cancer Res; 2011 Sep; 17(17):5546-52. PubMed ID: 21670084
[TBL] [Abstract][Full Text] [Related]
32. The regulation of N-methyl-D-aspartate receptors by Src kinase.
Groveman BR; Feng S; Fang XQ; Pflueger M; Lin SX; Bienkiewicz EA; Yu X
FEBS J; 2012 Jan; 279(1):20-8. PubMed ID: 22060915
[TBL] [Abstract][Full Text] [Related]
33. [ABL1, SRC and other non-receptor protein tyrosine kinases as new targets for specific anticancer therapy].
Klener P; Klener P
Klin Onkol; 2010; 23(4):203-9. PubMed ID: 20806817
[TBL] [Abstract][Full Text] [Related]
34. Targeting the yin and the yang: combined inhibition of the tyrosine kinase c-Src and the tyrosine phosphatase SHP-2 disrupts pancreatic cancer signaling and biology in vitro and tumor formation in vivo.
Gomes EG; Connelly SF; Summy JM
Pancreas; 2013 Jul; 42(5):795-806. PubMed ID: 23271399
[TBL] [Abstract][Full Text] [Related]
35. Src inhibitors in lung cancer: current status and future directions.
Rothschild SI; Gautschi O; Haura EB; Johnson FM
Clin Lung Cancer; 2010 Jul; 11(4):238-42. PubMed ID: 20630825
[TBL] [Abstract][Full Text] [Related]
36. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
[TBL] [Abstract][Full Text] [Related]
37. Src family kinases and pulmonary fibrosis: A review.
Li H; Zhao C; Tian Y; Lu J; Zhang G; Liang S; Chen D; Liu X; Kuang W; Zhu M
Biomed Pharmacother; 2020 Jul; 127():110183. PubMed ID: 32388241
[TBL] [Abstract][Full Text] [Related]
38. Nuclear Functions of the Tyrosine Kinase Src.
Bagnato G; Leopizzi M; Urciuoli E; Peruzzi B
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290470
[TBL] [Abstract][Full Text] [Related]
39. Src family kinase inhibitor PP2 accelerates differentiation in human intestinal epithelial cells.
Seltana A; Guezguez A; Lepage M; Basora N; Beaulieu JF
Biochem Biophys Res Commun; 2013 Jan; 430(4):1195-200. PubMed ID: 23274493
[TBL] [Abstract][Full Text] [Related]
40. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
